Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03006315 · ClinicalTrials.gov registry record
Mobile Health Device Study for Myeloma Patients
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 40
- Enrollment target
NCT03006315: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03006315 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03006315 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
Enrolled participants health status will be tracked by using a mobile health-monitoring device while undergoing chemotherapy for multiple myeloma.
Primary Outcome
Feasibility of using mobile wearable health device
Interventions
- DEVICE Garmin Vivofit device
- BEHAVIORAL Mobile Health quality of life assessements
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-12 |
| Est. Completion | 2024-11-14 |
What the finished NCT03006315 record still lists
NCT03006315 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Garmin Vivofit device is the first listed.
NCT03006315 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03006315 about?
NCT03006315 is a clinical study titled "Mobile Health Device Study for Myeloma Patients". Enrolled participants health status will be tracked by using a mobile health-monitoring device while undergoing chemotherapy for multiple myeloma.
What is the current status of trial NCT03006315?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2016-12. Estimated completion is 2024-11-14.
What interventions are being tested in trial NCT03006315?
The interventions under investigation include: Garmin Vivofit device (DEVICE), Mobile Health quality of life assessements (BEHAVIORAL).
Who is sponsoring clinical trial NCT03006315?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia